Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta—A Prospective Study
Table 1
Characteristics of subjects in the study groups at baseline. Values are expressed as median (range).
Group
Gender (m/f)
Age (years)
No. of patients aged less than 6 months
Weight (kg)
Height (cm)
BSA (m²)
Controls
76
32/44
5.4
12
20.4
113.8
0.79
(0.0–15.6)
(3.1–66.5)
(48.0–174.6)
(0.19–1.81)
Patients
21
7/14
5.2
0
20.0
105.1
0.78
with ASD
(2.3–14.9)
(12.4–59.0)
(83.0–163.0)
(0.53–1.63)
Patients
25
11/14
2.6
0
13.0
87.5
0.54
with PDA
(1.0–10.6)
(6.9–32.8)
(70.0–139.5)
(0.36–1.14)
Patients
15
8/7
2.0
7
14.0
91.5
0.59
with CoA
(0.0–15.5)
(3.4–56.6)
(49.5–164.0)
(0.20–1.57)
ASD: atrial septal defect; BSA: body surface area; CoA: coarctation of the aorta; PDA: patent ductus arteriosus.
